Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

People with Parkinson's disease and Lewy body dementia have increased rates of incident depression from seven to eight years ...

The U.S. Supreme Court agreed to hear a closely watched retirement plan lawsuit against Intel Corp., taking up a case that ...

An Alabama federal district court granted the Monroe County Board of Education and its superintendent’s motion for summary judgment, dismissing a Black female director of student services’ Title VII ...

Document fraud often involves altering legitimate documents or misusing blank originals. Hyperspectral analysis allows forensic experts to examine inks and colors at the pixel level and assess their ...

The results build on evidence U.S. regulators found so compelling last year they proactively awarded J&J a new kind of drug ...

The regulator’s Office of Prescription Drug Promotion (OPDP) has already sent out two letters alleging “false or misleading” ...

In the long-running active versus passive debate, the conversation tends to be centred on stocks. The concentration of global ...

ALX Oncology (NASDAQ:ALXO) outlined progress across its two clinical-stage programs—CD47 blocker evorpacept and EGFR-targeted ...

Victoria Omisore, who worked at Ford Dunton until November 2024, previously brought claims of direct race discrimination and against her employer ...

Patients with autoimmune hepatitis have no increased long-term risk for psychiatric disorders compared with the general population.

There are no salary caps, no aprons, and no luxury taxes, yet the world’s most-watched soccer league is only getting more balanced ...